January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...
A single, long-acting oral capsule can provide patients with schizophrenia or schizoaffective disord...
January The FDA approves the esketamine nasal spray Spravato as a monotherapy for adults with treatm...
A single, long-acting oral capsule can provide patients with schizophrenia or schizoaffective disord...